Session » Abstracts: Spondyloarthritis Including Psoriatic Arthritis – Basic Science (1752–1757)

Date: Tuesday, October 28, 2025

Time: 10:00AM-11:30AM

Meeting: ACR Convergence 2025

10:00AM-10:15AM: Abstract Number: 1752

Prg4+ Ligament Cells Are Involved in Ligament Ossification in Ankylosing Spondylitis

10:15AM-10:30AM: Abstract Number: 1753

Axial Psoriatic Arthritis is Phenocopied in a Humanized Mouse Model

10:30AM-10:45AM: Abstract Number: 1754

B3GNT2 Regulates Integrin β3 Glycosylation and Th17/Treg Imbalance in Axial Spondyloarthritis Pathogenesis

10:45AM-11:00AM: Abstract Number: 1755

Multi-Omic Profiling Of CD8+ T Cells In Axial Spondyloarthritis (axSpA) And Reactive Arthritis (ReA) Implicates Common Pathways

11:00AM-11:15AM: Abstract Number: 1756

Exosomal Cargo and Surface Markers: Informative Signals in Axial Spondyloarthritis

11:15AM-11:30AM: Abstract Number: 1757

Skin-to-Joint Immune Cell Migration and Synovial Reprogramming in Psoriatic Arthritis Onset

« View all sessions from this meeting

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].